Mitochondrial DNA polymorphisms in pathologically proven Parkinson’s disease
- 1 April 1997
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 244 (4), 262-265
- https://doi.org/10.1007/s004150050082
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Investigations on the Point Mutations at nt 5460 of the mtDNA in Different Neurodegenerative and Neuromuscular DiseasesEuropean Neurology, 1996
- A Greek‐American kindred with autosomal dominant, levodopa‐responsive parkinsonism and anticipationAnnals of Neurology, 1995
- PCR Analysis of platelet mtDNA: Lack of specific changes in Parkinson's diseaseMovement Disorders, 1993
- Quantitation of a mitochondrial DNA deletion in Parkinson's diseaseFEBS Letters, 1992
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Neurological disease and mitochondrial genesTrends in Neurosciences, 1991
- Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's diseaseBiochemical and Biophysical Research Communications, 1991
- Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I DefectJournal of Neurochemistry, 1990
- Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studiesMovement Disorders, 1990
- Dopaminergic neurotoxins, MPTP and MPP+, inhibit activity of mitochondrial NADH-ubiquinone oxidoreductase.Proceedings of the Japan Academy, Series B, 1986